DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 40 · March 2007 DOI: 10.1055/s-002-6627

Original Paper

47
Xiang, Y.-T.; Weng, Y.-Z.; Leung, C.-M.; Tang, W.-K.; Ungvari, G. S.: Clinical and Social Determinants of Antipsychotic Polypharmacy for Chinese Patients with Schizophrenia
53
Möller, H.-J.; Langer, S.; Schmauß, M.: Escitalopram in Clinical Practice: Results of an Open-Label Trial in Outpatients with Depression in a Naturalistic Setting in Germany
58
Cohen, S.; Kühn, K.-U.; Bender, S.; Erfurth, A.; Gastpar, M.; Murafi, A.; Rothermundt, M.; Signerski, J.; Sträter, B.; Teusch, L.; Weig, W.; Welling, A.; Westheide, J.; Huber, T. J.: Sexual Impairment in Psychiatric Inpatients: Focus on Depression
64
Gallinat, J.; Schubert, F.: Regional Cerebral Glutamate Concentrations and Chronic Tobacco Consumption
68
Calandre, E. P.; Morillas-Arques, P.; Rodriguez-Lopez, C. M.; Rico-Villademoros, F.; Hidalgo, J.: Pregabalin Augmentation of Quetiapine Therapy in the Treatment of Fibromyalgia: An Open-Label, Prospective Trial
72
Gerlach, M.; Hünnerkopf, R.; Rothenhöfer, S.; Libal, G.; Burger, R.; Clement, H.-W.; Fegert, J. M.; Wewetzer, Ch.; Mehler-Wex, C.: Therapeutic Drug Monitoring of Quetiapine in Adolescents with Psychotic Disorders
77
Linden, M.; Schotte, K.: A Randomized Controlled Clinical Trial Comparing “Guideline Exposed” and “Guideline Naive” Physicians in Respect to Dosage Selection and Treatment Outcome with Doxepin in Depressive Disorders

Letter

82
Koethe, D.; Dietl, T.; Leweke, F. M.; Friess, E.: Cessation of Complex Visual Hallucinations during Treatment with Mirtazapine
83
Hung, Galen Chin-Lun; Chen, Ying-Yeh: Extrapyramidal Side Effects Associated with Aripiprazole Administration in a Schizophrenic Patient
84
Yoshida, K.; Higuchi, H.; Ozaki, N.: Successful Treatment of Severe Antidepressant-Induced Nausea with a Combination of Milnacipran and Olanzapine
85
Khazaal, Y.; Zullino, D. F.: Rebound of Weight Gain Following Topiramate Cessation
86
Lange-Asschenfeldt, C.; Blaeser, I.; Supprian, T.: Bipolar Switching after Carbamazepine Withdrawal
87
Habermeyer, B.; Fuhr, P.: Authors' Reply Obessive-compulsive Disorders Due to Neuroacanthocytosis Treated with Citalopram